Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001339801-09-000001
Filing Date
2009-02-10
Accepted
2009-02-10 16:27:35
Documents
2
Period of Report
2009-02-06

Document Format Files

Seq Description Document Type Size
1 swe122.html 4  
1 swe122.xml 4 15896
2 POWER OF ATTORNEY cortdes.txt EX-24 2217
  Complete submission text file 0001339801-09-000001.txt   19852
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 755 PAGE MILL ROAD SUITE A-200 PALO ALTO CA 94304
Business Address 650-493-5600
SWEET DAVID E (Reporting) CIK: 0001339801 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50679 | Film No.: 09586082